Citigroup’s Monogram Orthopaedics MGRM Stock Holding History

Citigroup’s Portfolio MGRM Stock Details MGRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-775	Closed	-$4.55K	–	6299
2025 Q3	$4.55K	Sell	775 -1,225	-61%	-$6.54K	﹤0.01%	5257
2025 Q2	$5.78K	Hold	2,000	–	–	﹤0.01%	5260
2025 Q1	$5.88K	Hold	2,000	–	–	﹤0.01%	5258
2024 Q4	$4.74K	Buy	+2,000	New	+$4.69K	﹤0.01%	5466

Citigroup's MGRM Position: Q4 2025 in Review

Citigroup sold out of Monogram Orthopaedics (MGRM) in Q4 2025, closing a stake of 775 shares — an estimated $4.55K sold.

Citigroup first reported a position in MGRM in Q4 2024 and held it in 4 quarters. The position peaked at $5.88K in Q1 2025. 0 funds tracked by Wall St. Rank hold MGRM as of Q4 2025.

Citigroup reported no remaining Monogram Orthopaedics position as of Q4 2025 after selling out during the quarter.
Citigroup sold 775 Monogram Orthopaedics shares in Q4 2025, an estimated $4.55K.
Citigroup first reported a position in Monogram Orthopaedics in Q4 2024 and held it in 4 quarters.
Citigroup's Monogram Orthopaedics position peaked at $5.88K in Q1 2025.
0 funds tracked by Wall St. Rank held Monogram Orthopaedics as of Q4 2025.

Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.